98 related articles for article (PubMed ID: 16846474)
1. Downregulation of DBC1 expression in acute lymphoblastic leukaemia is mediated by aberrant methylation of its promoter.
San José-Enériz E; Agirre X; Román-Gómez J; Cordeu L; Garate L; Jiménez-Velasco A; Vázquez I; Calasanz MJ; Heiniger A; Torres A; Prósper F
Br J Haematol; 2006 Jul; 134(2):137-44. PubMed ID: 16846474
[TBL] [Abstract][Full Text] [Related]
2. Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in non-small cell lung cancers.
Izumi H; Inoue J; Yokoi S; Hosoda H; Shibata T; Sunamori M; Hirohashi S; Inazawa J; Imoto I
Hum Mol Genet; 2005 Apr; 14(8):997-1007. PubMed ID: 15746151
[TBL] [Abstract][Full Text] [Related]
3. Frequent hypermethylation of DBC1 in malignant lymphoproliferative neoplasms.
Grønbaek K; Ralfkiaer U; Dahl C; Hother C; Burns JS; Kassem M; Worm J; Ralfkiaer EM; Knudsen LM; Hokland P; Guldberg P
Mod Pathol; 2008 May; 21(5):632-8. PubMed ID: 18264085
[TBL] [Abstract][Full Text] [Related]
4. TP53 is frequently altered by methylation, mutation, and/or deletion in acute lymphoblastic leukaemia.
Agirre X; Novo FJ; Calasanz MJ; Larráyoz MJ; Lahortiga I; Valgañón M; García-Delgado M; Vizmanos JL
Mol Carcinog; 2003 Dec; 38(4):201-8. PubMed ID: 14639659
[TBL] [Abstract][Full Text] [Related]
5. Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia.
Agirre X; Román-Gómez J; Vázquez I; Jiménez-Velasco A; Garate L; Montiel-Duarte C; Artieda P; Cordeu L; Lahortiga I; Calasanz MJ; Heiniger A; Torres A; Minna JD; Prósper F
Int J Cancer; 2006 Apr; 118(8):1945-53. PubMed ID: 16287063
[TBL] [Abstract][Full Text] [Related]
6. WNT5A, a putative tumour suppressor of lymphoid malignancies, is inactivated by aberrant methylation in acute lymphoblastic leukaemia.
Roman-Gomez J; Jimenez-Velasco A; Cordeu L; Vilas-Zornoza A; San Jose-Eneriz E; Garate L; Castillejo JA; Martin V; Prosper F; Heiniger A; Torres A; Agirre X
Eur J Cancer; 2007 Dec; 43(18):2736-46. PubMed ID: 18032022
[TBL] [Abstract][Full Text] [Related]
7. Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.
Narayan G; Freddy AJ; Xie D; Liyanage H; Clark L; Kisselev S; Un Kang J; Nandula SV; McGuinn C; Subramaniyam S; Alobeid B; Satwani P; Savage D; Bhagat G; Murty VV
Genes Chromosomes Cancer; 2011 Dec; 50(12):1043-53. PubMed ID: 21960365
[TBL] [Abstract][Full Text] [Related]
8. A Possible Role for WNT5A Hypermethylation in Pediatric Acute Lymphoblastic Leukemia.
Hatırnaz Ng Ö; Fırtına S; Can İ; Karakaş Z; Ağaoğlu L; Doğru Ö; Celkan T; Akçay A; Yıldırmak Y; Timur Ç; Özbek U; Sayitoğlu M
Turk J Haematol; 2015 Jun; 32(2):127-35. PubMed ID: 26316480
[TBL] [Abstract][Full Text] [Related]
9. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation.
Li X; Liu J; Zhou R; Huang S; Huang S; Chen XM
Br J Haematol; 2010 Jan; 148(1):69-79. PubMed ID: 19807731
[TBL] [Abstract][Full Text] [Related]
10. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
[TBL] [Abstract][Full Text] [Related]
11. Aberrant promoter hypermethylation of selected apoptotic genes in childhood acute lymphoblastic leukemia among North Indian population.
Nikbakht M; Jha AK; Malekzadeh K; Askari M; Mohammadi S; Marwaha RK; Kaul D; Kaur J
Exp Oncol; 2017 Mar; 39(1):57-64. PubMed ID: 28361856
[TBL] [Abstract][Full Text] [Related]
12. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers.
Xie XM; Zhang ZY; Yang LH; Yang DL; Tang N; Zhao HY; Xu HT; Li QC; Wang EH
Int J Oncol; 2013 Nov; 43(5):1636-42. PubMed ID: 24002585
[TBL] [Abstract][Full Text] [Related]
13. High-frequency promoter hypermethylation of the deleted in liver cancer-1 gene in multiple myeloma.
Song YF; Xu R; Zhang XH; Chen BB; Chen Q; Chen YM; Xie Y
J Clin Pathol; 2006 Sep; 59(9):947-51. PubMed ID: 16489177
[TBL] [Abstract][Full Text] [Related]
14. Absence of global hypomethylation in promoter hypermethylated Mixed Lineage Leukaemia-rearranged infant acute lymphoblastic leukaemia.
Stumpel DJ; Schneider P; van Roon EH; Pieters R; Stam RW
Eur J Cancer; 2013 Jan; 49(1):175-84. PubMed ID: 22921182
[TBL] [Abstract][Full Text] [Related]
15. Residual methylation of tumor suppressor gene promoters, RASSF6 and RASSF10, as novel biomarkers for minimal residual disease detection in adult acute lymphoblastic leukemia.
Younesian S; Shahkarami S; Ghaffari P; Alizadeh S; Mehrasa R; Ghaffari SH
Ann Hematol; 2019 Dec; 98(12):2719-2727. PubMed ID: 31486880
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
[TBL] [Abstract][Full Text] [Related]
17. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
18. Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemia.
Matsushita C; Yang Y; Takeuchi S; Matsushita M; Van Dongen JJ; Szczepanski T; Bartram CR; Seo H; Koeffler HP; Taguchi H
Oncol Rep; 2004 Jul; 12(1):97-9. PubMed ID: 15201966
[TBL] [Abstract][Full Text] [Related]
19. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
Zhao L; Cui Q; Lu Z; Chen J
Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
[TBL] [Abstract][Full Text] [Related]
20. Preferential hypermethylation of the Dickkopf-1 promoter in core-binding factor leukaemia.
Suzuki R; Onizuka M; Kojima M; Shimada M; Fukagawa S; Tsuboi K; Kobayashi H; Shintani A; Ogawa Y; Kawada H; Hotta T; Ando K
Br J Haematol; 2007 Sep; 138(5):624-31. PubMed ID: 17686056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
